Caspase inhibitors (original) (raw)

Cell Death & Differentiation volume 6, pages 1081–1086 (1999)Cite this article

Abstract

Caspases are the key effector molecules of the physiological death process known as apoptosis, although some are involved in activation of cytokines, rather than cell death. They exist in most of our cells as inactive precursors (zymogens) that kill the cell once activated. Caspases can be controlled in two ways. The processing and activation of a caspase can be regulated by molecules such as FADD, APAF-1, Bcl-2 family members, FLIP and IAPs. Active caspases can be controlled by a variety of inhibitors that directly interact with the protease. This review describes the later direct caspase inhibitors that have been identified, products of both viral and cellular genes, and artificial caspase inhibitors that have been developed both as research tools and as pharmaceutical agents to inhibit cell death in vivo.

Similar content being viewed by others

Article PDF

Author information

Authors and Affiliations

  1. The Walter and Eliza Hall Institute of Medical Research, c/o Post Office Royal Melbourne Hospital, 3050, Victoria, Australia
    PG Ekert, J Silke & DL Vaux

Authors

  1. PG Ekert
    You can also search for this author inPubMed Google Scholar
  2. J Silke
    You can also search for this author inPubMed Google Scholar
  3. DL Vaux
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toPG Ekert.

Additional information

Edited by G Melino

Rights and permissions

About this article

Cite this article

Ekert, P., Silke, J. & Vaux, D. Caspase inhibitors.Cell Death Differ 6, 1081–1086 (1999). https://doi.org/10.1038/sj.cdd.4400594

Download citation

Keywords

This article is cited by